Italian Studies Confirm Safety of HOPE (Hypothermic Oxygenated PErfusion) for Liver Transplantation and Value of HOPE in Identifying Biomarkers for Assessing Liver Viability

"Our academic research centre has been at the forefront of evaluating the impact of HOPE in several aspects of liver transplantation," said Dr Damiano Patrono, MD, Liver Transplant Unit, AOU Città della Salute e della Scienza di Torino, Italy and principal investigator of the three trials. "We continue to be impressed with the value that the use of HOPE brings to increasing the supply of available livers for transplantation, potentially improving access for those in need of livers and reducing waiting time for transplantation," he further commented.

Istanbul, Turkey, 23/09/2024 (informazione.it - comunicati stampa - salute e benessere)

"Our academic research centre has been at the forefront of evaluating the impact of HOPE in several aspects of liver transplantation," said Dr Damiano Patrono , MD, Liver Transplant Unit, AOU Città della Salute e della Scienza di Torino, Italy and principal investigator of the three trials. "We continue to be impressed with the value that the use of HOPE brings to increasing the supply of available livers for transplantation, potentially improving access for those in need of livers and reducing waiting time for transplantation," he further commented.

"These Italian studies are further support for the value that HOPE can contribute to the transplantation community worldwide," commented Don Webber , CEO and President of Bridge to Life Ltd., a leading provider of transplant solutions and a sponsor of the studies. "We are in the final stages of assessing the 1-year follow-up results of our HOPE Trial in the U.S. and look forward to bringing this innovative technology to U.S. transplant centers, organ procurement organizations, and, most importantly, to patients in need of viable livers," he added.

The three presentations include:

, ID #373, D. Patrono (General Surgery 2U - Liver Transplant Unit, AOU Città della Salute e della Scienza di Torino ), et al

, ID #453, S. Corcione (General Surgery 2U - Liver Transplant Unit, AOU Città della Salute e della Scienza di Torino ), et al

, ID #828, T. Carradori (General Surgery 2U - Liver Transplant Unit, AOU Città della Salute e della Scienza di Torino ), et al

Bridge to Life Ltd is a market leader in organ preservation solutions, offering premier products such as Belzer UW, EasiSlush and the VitaSmart Machine Perfusion System. With a strong focus on product quality, innovation and accessibility, the company serves and partners with leading Transplant Centers and Organ Procurement Offices (OPO) globally.

View original content: https://www.prnewswire.co.uk/news-releases/italian-studies-confirm-safety-of-hope-hypothermic-oxygenated-perfusion-for-liver-transplantation-and-value-of-hope-in-identifying-biomarkers-for-assessing-liver-viability-302254350.html